- Research works
- 35 ▲ 162% vs 2013–17
- Citations
- 1.8k 49.9 per fractional work
- Top-10% rate
- 5.2% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Starpharma (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.0×
- Medicine 2.8×
- Chemistry 2.5×
- Immunology and Microbiology 1.5×
- Earth and Planetary Sciences 1.4×
- Environmental Science 1.2×
- Materials Science 1.1×
- Economics, Econometrics and Finance 0.7×
- Agricultural and Biological Sciences 0.5×
- Business, Management and Accounting 0.5×
- Social Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.0×
Which keywords describe research at Starpharma (Australia)?
By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Biomedical Applications, Drug Delivery, Synthesis, Catalysis, Toxicity, Gene Therapy and Dendrimers.
- Peptide Synthesis
- Foldamers
- Cancer
- Surface Engineering
- Nanocarriers
- Tumor Targeting
- Inflammation
- Immune Response
- RNA Interference
- Epidemiology
- Gene Therapy
- Toxicity
- Synthesis
- Biomedical Applications
- Nanoparticles
- Drug Delivery
- Catalysis
- Dendrimers
- Hyperbranched Polymers
- Vaccine
- siRNA Delivery
- Drug Discovery
- Cancer Therapy
- Antiretroviral Therapy
- Sexually Transmitted Infections
- Bacterial Vaginosis
- Vaginal Microbiome
- HIV
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 28 words, with their numbers
- Nanoparticles6▲ 14×6 topics
- Biomedical Applications5▲ 13×3 topics
- Drug Delivery5▲ 30×3 topics
- Synthesis4▲ 20×3 topics
- Catalysis4▲ 14×4 topics
- Toxicity4▲ 26×3 topics
- Dendrimers4▲ 728×1 topic
- Gene Therapy4▲ 40×3 topics
- Hyperbranched Polymers4▲ 728×1 topic
- Epidemiology4▲ 2.5×15 topics
- Vaccine3▲ 23×7 topics
- RNA Interference3▲ 78×1 topic
- siRNA Delivery3▲ 116×1 topic
- Immune Response3▲ 13×6 topics
- Drug Discovery2▲ 12×3 topics
- Inflammation2▲ 2.1×12 topics
- Cancer Therapy2▲ 7.0×4 topics
- Tumor Targeting2▲ 35×3 topics
- Antiretroviral Therapy1▲ 16×2 topics
- Nanocarriers1▲ 77×1 topic
- Sexually Transmitted Infections1▲ 59×2 topics
- Surface Engineering1▲ 29×1 topic
- Bacterial Vaginosis1▲ 104×1 topic
- Cancer1▲ 2.1×4 topics
- Vaginal Microbiome1▲ 104×1 topic
- Foldamers1▲ 36×1 topic
- HIV1▲ 24×2 topics
- Peptide Synthesis1▲ 36×1 topic
Which research topics does Starpharma (Australia) publish most on?
By volume in 2022–2025: Cancer Research and Treatments, Click Chemistry and Applications, Lysosomal Storage Disorders Research and Intraperitoneal and Appendiceal Malignancies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 0 works
- 2 Click Chemistry and Applications Organic Chemistry 0 works
- 3 Lysosomal Storage Disorders Research Physiology 0 works
- 4 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
- 5 Neuroblastoma Research and Treatments Neurology 0 works
- 6 Head and Neck Surgical Oncology Surgery 0 works
- 7 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 0 works
- 8 Bacterial biofilms and quorum sensing Molecular Biology 0 works
- 9 COVID-19 Impact on Reproduction Obstetrics and Gynecology 0 works
- 10 Phytochemical compounds biological activities Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Starpharma (Australia)'s research output changed?
Output in 2018–2022 was 162% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Melbourne
- The University of Melbourne
- Monash University
- La Trobe University
- RMIT University
- Swinburne University of Technology
- The Royal Melbourne Hospital
- Victoria University
- Royal Children's Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.